- Lomina's Divisions:
- Human Diagnostics
- Veterinary Diagnostics
- Genetics Lab
Menu
Menu
The kit is used for the qualitative detection of new coronavirus SARS-CoV-2 nucleocapsid (N) antigen in human Oro and Nasopharyngeal swab samples in vitro.
It is used as a supplementary detection indicator for suspected cases of new coronavirus negative nucleic acid detection or used in conjunction with nucleic acid detection in the diagnosis of suspected cases. It cannot be used as a basis for the diagnosis and exclusion of pneumonitis infected by new coronavirus.
The test is developed and tested for the use of nasopharyngeal or oropharyngeal swab samples.
Nasopharyngeal
Oropharyngeal
Sensitivity: 91,29% (CI 95%: 87,73%-94,09%)
Specificity: 98,61% (CI 95%: 97,99%-99,01%)
One band/line appears in the control region „C“, and another band/line appears in the „T“ region (picture A).
Only one band/line appears in the control region „C“ with no other bar sign elsewhere. (picture B)
No band/line appears in the control region (C), whether
a test band „T“ is present or not. Repeat invalid tests with a new sample, new test device and reagent. Insufficient sample volume, inaccurate operating procedure or expired tests may yield an invalid result. Contact your local distributor if the problem continues. (picture C).
As a globally active European brand, we distribute our portfolio of products to an extensive network of our business partners’ brick-and-mortar shops and e-shops.
